These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 24516119)
1. Rapamycin antagonizes TNF induction of VCAM-1 on endothelial cells by inhibiting mTORC2. Wang C; Qin L; Manes TD; Kirkiles-Smith NC; Tellides G; Pober JS J Exp Med; 2014 Mar; 211(3):395-404. PubMed ID: 24516119 [TBL] [Abstract][Full Text] [Related]
2. Downregulation of GATA6 in mTOR-inhibited human aortic endothelial cells: effects on TNF-α-induced VCAM-1 expression and monocytic cell adhesion. Fan X; Chen X; Feng Q; Peng K; Wu Q; Passerini AG; Simon SI; Sun C Am J Physiol Heart Circ Physiol; 2019 Feb; 316(2):H408-H420. PubMed ID: 30462552 [TBL] [Abstract][Full Text] [Related]
3. Endothelial Cell mTOR Complex-2 Regulates Sprouting Angiogenesis. Farhan MA; Carmine-Simmen K; Lewis JD; Moore RB; Murray AG PLoS One; 2015; 10(8):e0135245. PubMed ID: 26295809 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of histone deacetylase overcomes rapamycin-mediated resistance in diffuse large B-cell lymphoma by inhibiting Akt signaling through mTORC2. Gupta M; Ansell SM; Novak AJ; Kumar S; Kaufmann SH; Witzig TE Blood; 2009 Oct; 114(14):2926-35. PubMed ID: 19641186 [TBL] [Abstract][Full Text] [Related]
5. Rapamycin ameliorates inflammation and fibrosis in the early phase of cirrhotic portal hypertension in rats through inhibition of mTORC1 but not mTORC2. Wang W; Yan J; Wang H; Shi M; Zhang M; Yang W; Peng C; Li H PLoS One; 2014; 9(1):e83908. PubMed ID: 24404143 [TBL] [Abstract][Full Text] [Related]
6. Mechanistic Target of Rapamycin Complex 1 (mTORC1) and mTORC2 as Key Signaling Intermediates in Mesenchymal Cell Activation. Walker NM; Belloli EA; Stuckey L; Chan KM; Lin J; Lynch W; Chang A; Mazzoni SM; Fingar DC; Lama VN J Biol Chem; 2016 Mar; 291(12):6262-71. PubMed ID: 26755732 [TBL] [Abstract][Full Text] [Related]
7. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes. Jhanwar-Uniyal M; Gillick JL; Neil J; Tobias M; Thwing ZE; Murali R Adv Biol Regul; 2015 Jan; 57():64-74. PubMed ID: 25442674 [TBL] [Abstract][Full Text] [Related]
8. CD40-induced signaling in human endothelial cells results in mTORC2- and Akt-dependent expression of vascular endothelial growth factor in vitro and in vivo. Dormond O; Contreras AG; Meijer E; Datta D; Flynn E; Pal S; Briscoe DM J Immunol; 2008 Dec; 181(11):8088-95. PubMed ID: 19018001 [TBL] [Abstract][Full Text] [Related]
9. In human endothelial cells rapamycin causes mTORC2 inhibition and impairs cell viability and function. Barilli A; Visigalli R; Sala R; Gazzola GC; Parolari A; Tremoli E; Bonomini S; Simon A; Closs EI; Dall'Asta V; Bussolati O Cardiovasc Res; 2008 Jun; 78(3):563-71. PubMed ID: 18250144 [TBL] [Abstract][Full Text] [Related]
10. Regulation of endothelial cell proliferation and vascular assembly through distinct mTORC2 signaling pathways. Wang S; Amato KR; Song W; Youngblood V; Lee K; Boothby M; Brantley-Sieders DM; Chen J Mol Cell Biol; 2015 Apr; 35(7):1299-313. PubMed ID: 25582201 [TBL] [Abstract][Full Text] [Related]
11. RhoA modulates signaling through the mechanistic target of rapamycin complex 1 (mTORC1) in mammalian cells. Gordon BS; Kazi AA; Coleman CS; Dennis MD; Chau V; Jefferson LS; Kimball SR Cell Signal; 2014 Mar; 26(3):461-7. PubMed ID: 24316235 [TBL] [Abstract][Full Text] [Related]
12. Targeted inhibition of mTORC2 prevents osteosarcoma cell migration and promotes apoptosis. Wang X; Lai P; Zhang Z; Huang M; Wang L; Yin M; Jin D; Zhou R; Bai X Oncol Rep; 2014 Jul; 32(1):382-8. PubMed ID: 24840134 [TBL] [Abstract][Full Text] [Related]
13. Synergistic Effects between mTOR Complex 1/2 and Glycolysis Inhibitors in Non-Small-Cell Lung Carcinoma Cells. Jiang S; Zou Z; Nie P; Wen R; Xiao Y; Tang J PLoS One; 2015; 10(7):e0132880. PubMed ID: 26176608 [TBL] [Abstract][Full Text] [Related]
14. A comparison of Ku0063794, a dual mTORC1 and mTORC2 inhibitor, and temsirolimus in preclinical renal cell carcinoma models. Zhang H; Berel D; Wang Y; Li P; Bhowmick NA; Figlin RA; Kim HL PLoS One; 2013; 8(1):e54918. PubMed ID: 23349989 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of 14-3-3 binding to Rictor of mTORC2 for Akt phosphorylation at Ser473 is regulated by selenoprotein W. Jeon YH; Park YH; Kwon JH; Lee JH; Kim IY Biochim Biophys Acta; 2013 Oct; 1833(10):2135-42. PubMed ID: 23680186 [TBL] [Abstract][Full Text] [Related]
16. Rapamycin inhibits ox-LDL-induced inflammation in human endothelial cells in vitro by inhibiting the mTORC2/PKC/c-Fos pathway. Sun JJ; Yin XW; Liu HH; Du WX; Shi LY; Huang YB; Wang F; Liu CF; Cao YJ; Zhang YL Acta Pharmacol Sin; 2018 Mar; 39(3):336-344. PubMed ID: 29072256 [TBL] [Abstract][Full Text] [Related]
17. Rapamycin attenuates BAFF-extended proliferation and survival via disruption of mTORC1/2 signaling in normal and neoplastic B-lymphoid cells. Zeng Q; Qin S; Zhang H; Liu B; Qin J; Wang X; Zhang R; Liu C; Dong X; Zhang S; Huang S; Chen L J Cell Physiol; 2018 Jan; 233(1):516-529. PubMed ID: 28300280 [TBL] [Abstract][Full Text] [Related]
18. Rapamycin attenuates endothelial apoptosis induced by low shear stress via mTOR and sestrin1 related redox regulation. Zhang J; Wang Z; Zhang J; Zuo G; Li B; Mao W; Chen S Mediators Inflamm; 2014; 2014():769608. PubMed ID: 24587596 [TBL] [Abstract][Full Text] [Related]
19. [Research on multiple myeloma cell apoptosis by inhibition of mTORC2 and chaperon pathways]. Fu Y; Zhang Y; Zhang F; Liu J; Gui R Zhonghua Xue Ye Xue Za Zhi; 2015 Sep; 36(9):780-4. PubMed ID: 26462781 [TBL] [Abstract][Full Text] [Related]
20. Rapamycin inhibits mSin1 phosphorylation independently of mTORC1 and mTORC2. Luo Y; Liu L; Wu Y; Singh K; Su B; Zhang N; Liu X; Shen Y; Huang S Oncotarget; 2015 Feb; 6(6):4286-98. PubMed ID: 25738366 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]